Main > HEMATOLOGY > Paroxysmal Nocturnal HemoglobinUria > Treatment > Co: USA. A. EculizuMAb



Co: USA. A. EculizuMAb's subsections
(*) JP Approval Date: 2010. 04.16
(*) USA Approval Date: ?
C5 Complement Inhibitors
Company
Patent>Assignee, Claims, No., Etc
Patent>Total USA No.: 9
Patent>UpDate: 2017. 08.15
Patent>USA Expiration: 2027
TradeMark
TradeMark Web-Site

Co: USA. A. EculizuMAb's products
This section has no products